BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38749063)

  • 1. Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice.
    Ho AS; Davies L; Yeh MW
    JAMA Otolaryngol Head Neck Surg; 2024 May; ():. PubMed ID: 38749063
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
    Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
    Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
    [No Abstract]   [Full Text] [Related]  

  • 3. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review.
    Chou R; Dana T; Haymart M; Leung AM; Tufano RP; Sosa JA; Ringel MD
    Thyroid; 2022 Apr; 32(4):351-367. PubMed ID: 35081743
    [No Abstract]   [Full Text] [Related]  

  • 4. Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
    Fujishima M; Miyauchi A; Ito Y; Kudo T; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
    Endocr J; 2023 Apr; 70(4):411-418. PubMed ID: 36631086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
    Ito Y; Miyauchi A
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
    [No Abstract]   [Full Text] [Related]  

  • 6. Active surveillance of low-risk papillary thyroid microcarcinomas.
    Ito Y; Miyauchi A
    Gland Surg; 2020 Oct; 9(5):1663-1673. PubMed ID: 33224844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives.
    Zhu P; Zhang Q; Wu Q; Shi G; Wang W; Xu H; Zhang L; Qian M; Hegarty J
    Thyroid; 2023 Jul; 33(7):826-834. PubMed ID: 36719782
    [No Abstract]   [Full Text] [Related]  

  • 8. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
    Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance.
    Sasaki T; Miyauchi A; Fujishima M; Ito Y; Kudo T; Noda T; Sano T; Kishi T; Nakamura T
    Thyroid; 2023 Feb; 33(2):186-191. PubMed ID: 36205580
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
    Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance of low-risk papillary thyroid microcarcinoma.
    Sugitani I
    Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
    Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
    Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
    Griffin A; Brito JP; Bahl M; Hoang JK
    Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
    Jensen CB; Saucke MC; Pitt SC
    BMC Cancer; 2021 Apr; 21(1):471. PubMed ID: 33910527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance for patients with very low-risk thyroid cancer.
    Lohia S; Hanson M; Tuttle RM; Morris LGT
    Laryngoscope Investig Otolaryngol; 2020 Feb; 5(1):175-182. PubMed ID: 32128446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.
    Roman BR; Brito JP; Saucke MC; Lohia S; Jensen CB; Zaborek N; Jennings JL; Tuttle RM; Davies L; Pitt SC
    Endocr Pract; 2021 Jan; 27(1):1-7. PubMed ID: 33471727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide.
    Aygün N; İşgör A; Uludağ M
    Sisli Etfal Hastan Tip Bul; 2018; 52(4):233-243. PubMed ID: 32774084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
    Ito Y; Miyauchi A; Oda H
    Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled Trial.
    Ho AS; Kim S; Zalt C; Melany ML; Chen IE; Vasquez J; Mallen-St Clair J; Chen MM; Vasquez M; Fan X; van Deen WK; Haile RW; Daskivich TJ; Zumsteg ZS; Braunstein GD; Sacks WL
    JAMA Oncol; 2022 Sep; 8(11):1588-96. PubMed ID: 36107411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.